SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
Sep 18, 2023	15-12G	15-12G	Surface Oncology	0001193125-23-236303.pdf 0001193125-23-236303.rtf 0001193125-23-236303.xls View HTML
Sep 12, 2023	EFFECT	EFFECT	Surface Oncology	9999999995-23-002629.pdf 9999999995-23-002629.rtf 9999999995-23-002629.xls View HTML
Sep 12, 2023	EFFECT	EFFECT	Surface Oncology	9999999995-23-002628.pdf 9999999995-23-002628.rtf 9999999995-23-002628.xls View HTML
Sep 08, 2023	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001193125-23-231197.pdf 0001193125-23-231197.rtf 0001193125-23-231197.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Sep 08, 2023	25-NSE	25-NSE	Surface Oncology	0001354457-23-000642.pdf 0001354457-23-000642.rtf 0001354457-23-000642.xls View HTML
Sep 08, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-048764.pdf 0001209191-23-048764.rtf 0001209191-23-048764.xls View HTML
Sep 08, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-048757.pdf 0001209191-23-048757.rtf 0001209191-23-048757.xls View HTML
Sep 08, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-048762.pdf 0001209191-23-048762.rtf 0001209191-23-048762.xls View HTML
Sep 08, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-048760.pdf 0001209191-23-048760.rtf 0001209191-23-048760.xls View HTML
Sep 08, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-048761.pdf 0001209191-23-048761.rtf 0001209191-23-048761.xls View HTML

Data provided by Kaleidoscope.